The Feinstein Institute for Medical Research’s Chad Bouton joined colleagues from the Defense Advanced Research Projects Agency (DARPA) and Massachusetts Institute of Technology (MIT) to discuss the future of the emerging field of bioelectronic medicine as part of a panel at SXSW Interactive, America’s premier festival of technological and scientific innovation. Clinical trials of bioelectronic treatments for various conditions, and improving prosthetics for amputees were among the wide-ranging topics tackled during this panel titled, “The Future Body: Modulating the Nervous System.”
2016 Key Symposium
In September 2016, thought leaders who have the potential to explore, define, and create bioelectronic medicine convened at the Key Symposium.
Session topics included: Defining Circuits, Cell Biology and Cancer, Molecular Sensing, Clinical Updates, Brain Interfaces, Processing the Future, and Funding the Field. By harnessing the power of technology spanning disciplines from microfluidics to computer processing to molecular technology, we step closer to the promise of bioelectronic medicine — to naturally reproduce a drug’s therapeutic reaction by mobilizing the body’s natural reflexes to develop effective, safe and economical alternatives to pills and injectables.
The symposium concluded with a panel entitled “What Life Will Be Like When We Can Fully Modulate the Nervous System: The Impact on Disease, Drugs, the Healthcare Industry, Personal Freedom, and Privacy.” Moderated by PBS’s science correspondent, Miles O’Brien, and featuring panelists from the Feinstein Institute, Massachusetts Institute of Technology (MIT), Sweden’s Karolinska Institute, and Defense Advanced Research Projects Agency (DARPA), the panel explored the far-reaching benefits and consequences that are likely to accompany the ascent of bioelectronics medicine.
To view the panel discussion, click on the video below.
2016 Forbes Healthcare Summit
Kevin J. Tracey, MD, Presentation on Bioelectronic Medicine